non-animal alternatives testing market
Professional Services

Insights Into The Non-Animal Alternatives Testing Market’s Growth Opportunities Through 2023-2032 – Includes Non-Animal Alternatives Testing Market Size

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

 

The support from the government and non-governmental organizations are expected to drive innovation in non-animal alternatives testing manufacturing, thus driving the market during the forecast period.

 

The global non-animal alternatives testing market is expected to grow from $1.78 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The non-animal alternatives testing market is expected to grow from $2.9 billion in 2027 at a CAGR of 10.5%.

 

Get A Free Sample On The Global Non-Animal Alternatives Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2819&type=smp

 

Global Non-Animal Alternatives Testing Market Segments Include:

  • By Technology: Cell Culture Technology, High Throughput Technology, Molecular Imaging, Omics Technology, Other Technologies
  • By Method: Cellular Assay, Biochemical Assay, In SiliCo., Ex-vivo
  • By End-User: Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry
  • By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the global non-animal alternatives testing market in 2021.

 

Major Market Players in the non-animal alternatives testing market include MatTek Corporation, Cyprotex, Emulate Inc., BioIVT, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories and Gentronix Limited.

 

OOCs (organs-on-chips) tool for testing is a major trend in the non-animal alternatives testing market. Organs-on-a-chips (OOCs) are miniature tissues and organs grown in-vitro that enable the modelling of human physiology and disease. OOCs are now being explored worldwide as tools for developing disease models and accurately predicting drug efficacies and toxicities. The advantages of OOCs over cell culture, animal models, and human clinical trials have captured the attention of both the medical and pharmaceutical communities, focusing on developing targeted therapies. For instance, in April 2020, researchers at the Massachusetts Institute of Technology (MIT) in the US developed a new model for Organs-on-a-Chip to develop treatments for inflammatory diseases and afflictions. Organs-on-a-chip consist of millions of cells formed on a platform to replicate the functions of different organs and can be used as an instrument in analysing and creating new treatments for complex diseases without the use of animals for testing.

 

The Non-Animal Alternatives Testing Global Market Report 2023  provides a non-animal alternatives testing market overview for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The non-animal alternatives testing market forecast analyzes non-animal alternatives testing market size, non-animal alternatives testing market share, leading competitor market positions. The regions covered in the report include Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa and the countries include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

 

The non-animal alternatives testing is testing products and services that do not involve testing on animals to determine the safety and efficacy of products and ingredients used in any industry sector. Non-animal alternative testing technologies include: in-vitro human cell and tissue cultures; organs-on-chips (OOCs); computer simulations and modelling (silico models); 3D bio-printing of tissues; and synthetic skin substitutes; as well as studies with human volunteers. These technologies replace animal testing in end-use industries including pharmaceuticals, medical devices, chemicals and pesticides, food, and others.

 

Explore Similar Reports From The Business Research Company:

Antimicrobial Susceptibility Testing Global Market Report 2023

Noninvasive Prenatal Testing Global Market Report 2023

Animal Food Global Market Report 2023

 

Learn More About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

 

Contact Us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Check out our:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

 

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *